| | | | | | Product | Package Size | EFP | CP | SB | DC | Composition | Registr. Holder | Category | | | | |
|---|
| What is an ATC-Code? | ATC-Overview |
|
| | | IP | | | Erythrocin i.v. | ampoule(s) | PR | 52.90 | k.A. | | Lyophilisate: Erythromycinum 1000 mg | Advanz Pharma
Specialty Medicine
Switzerland GmbH | B | FB | | G |  |
| | | IP | CI | | Karex 250 | 14 Tablet(s) | 12.15 | 21.65 | k.A. | | Tablets: Erythromycinum 250 mg | Teva Pharma AG | B | FB | | G | |
| | | IP | CI | | Karex 500 | 14 Tablet(s) | 23.95 | 42.75 | k.A. | | Tablets: Erythromycinum 500 mg | Teva Pharma AG | B | FB | | G | |
| | | IP | CI | | Karex 500 | 21 Tablet(s) | PR | 61.20 | k.A. | | Tablets: Erythromycinum 500 mg | Teva Pharma AG | B | FB | | G | |
|
| | | IP | CI | | Klacid 250 mg - T | 14 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 250 mg - T | 20 Tablet(s) | 14.65 | 32.20 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| L | | IP | CI | | Klacid 250 mg - T | 70 Tablet(s) | 46.51 | 67.00 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 500 mg - T | 14 Tablet(s) | 16.65 | 34.45 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Viatris Pharma GmbH | ● A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 500 mg - T | 20 Tablet(s) | 25.60 | 44.10 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Viatris Pharma GmbH | ● A / SL / SO | FB | | G | |
| | | IP | CI | | Klacid 500 mg - T | 30 Tablet(s) | 35.61 | 54.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Viatris Pharma GmbH | ● A / SL / SO | FB | | G | |
| | | IP | CI | | Klaciped | 100 ml | 6.00 | 15.75 | 10 % | | Kindersuspension: Clarithromycinum 125 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Klaciped Forte | 100 ml | 10.90 | 28.20 | 10 % | | Kindersuspension: Clarithromycinum 250 mg | Viatris Pharma GmbH | A / SL / SO | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 250 - T | 14 Tablet(s) | 10.01 | 27.25 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 250 - T | 20 Tablet(s) | 12.47 | 29.95 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 14 Tablet(s) | 15.18 | 32.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 20 Tablet(s) | 23.88 | 42.35 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 250 mg | 14 | 9.30 | 26.55 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 250 mg | 20 | 12.39 | 29.90 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 14 | 15.18 | 32.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 20 | 23.13 | 41.55 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 14 | 9.29 | 26.55 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 20 | 12.38 | 29.90 | 10 % | | Coated tablets: Clarithromycinum 250 mg | Mepha Pharma AG | ● A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 14 | 15.18 | 32.95 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 20 | 21.66 | 40.05 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 30 | 32.13 | 51.35 | 10 % | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 125 | 100 ml | 5.93 | 15.70 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 125 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC
forte 250 | 100 ml | 9.98 | 27.25 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 250 mg | Spirig HealthCare AG | ● A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 125 | 100 ml | 5.48 | 15.20 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 125 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 100 ml | 9.98 | 27.25 | 10 % | | Granulat zur Herstellung einer Suspension zum Einnehmen: Clarithromycinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| L | | IP | | | Klacid i.v. | ampoule(s) | 17.70 | 35.65 | 10 % | | Infusion preparation: Clarithromycinum 500 mg | Viatris Pharma GmbH | A / SL | FB | | G | |
| | | IP | | | Clarithromycine Labatec 500 mg
i.v. | 500 mg | PR | PR | k.A. | | Dry substance: Clarithromycinum 500 mg | Labatec Pharma SA | A | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 250 - T | 70 Tablet(s) | PR | PR | k.A. | | Coated tablets: Clarithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 30 Tablet(s) | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin Sandoz 500 - T | 120 Tablet(s) | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin Spirig HC 250 mg | 70 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 250 mg | Spirig HealthCare AG | A | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 30 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A | FB | | G | |
| | | IP | | | Clarithromycin Spirig HC 500 mg | 120 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Spirig HealthCare AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 250 | 70 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 250 mg | Mepha Pharma AG | A | FB | | G | |
| | | IP | CI | | Clarithromycin-Mepha 500 | 120 | PR | PR | k.A. | | Coated tablets: Clarithromycinum 500 mg | Mepha Pharma AG | A | FB | | G | |
|
| | | IP | CI | | Azithromycin-Mepha 200 | 15 ml | 4.67 | 14.30 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin-Mepha 200 | 30 ml | 8.93 | 26.10 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Zithromax 250 mg - T | 4 Tablet(s) | 6.80 | 16.60 | 10 % | | Coated tablets: Azithromycinum 250 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Zithromax 250 mg - T | 6 Tablet(s) | 10.21 | 27.45 | 10 % | | Coated tablets: Azithromycinum 250 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Zithromax 500 mg | 3 Tablet(s) | 10.21 | 27.45 | 10 % | | Coated tablets: Azithromycinum 500 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Zithromax | 15 ml | 5.15 | 14.80 | 20 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Zithromax | 30 ml | 8.96 | 26.15 | 20 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | CM | Azithromycin Pfizer 250 mg | 4 Tablet(s) | 7.71 | 17.55 | 10 % | | Coated tablets: Azithromycinum 250 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Azithromycin Pfizer 250 mg | 6 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: Azithromycinum 250 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Azithromycin Pfizer 500 mg | 3 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: Azithromycinum 500 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Sandoz 250 | 4 Tablet(s) | 6.19 | 16.00 | 10 % | | Coated tablets: Azithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Sandoz 250 | 6 Tablet(s) | 9.30 | 26.55 | 10 % | | Coated tablets: Azithromycinum 250 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Sandoz 500 | 3 Tablet(s) | 9.29 | 26.50 | 10 % | | Coated tablets: Azithromycinum 500 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Spirig HC 250 mg | 4 | 6.19 | 16.00 | 10 % | | Coated tablets: Azithromycinum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Spirig HC 250 mg | 6 | 9.29 | 26.50 | 10 % | | Coated tablets: Azithromycinum 250 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | | | Azithromycin Spirig HC 500 mg | 3 | 9.29 | 26.50 | 10 % | | Coated tablets: Azithromycinum 500 mg | Spirig HealthCare AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin-Mepha 250 mg | 4 | 6.24 | 16.05 | 10 % | | Coated tablets: Azithromycinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin-Mepha 250 mg | 6 | 9.30 | 26.55 | 10 % | | Coated tablets: Azithromycinum 250 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | | | Azithromycin-Mepha 500 mg | 3 | 9.30 | 26.55 | 10 % | | Coated tablets: Azithromycinum 500 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Azithromycin Pfizer | 15 ml | 4.70 | 14.35 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Azithromycin Pfizer | 30 ml | 8.96 | 26.15 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Sandoz | 15 ml | 4.67 | 14.30 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Azithromycin Sandoz | 30 ml | 8.15 | 25.30 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Zithromax 100 mg | 3 Sachet(s) | 3.15 | 12.65 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen im Beutel: Azithromycinum 100 mg | Pfizer AG | A / SL | FB | | G | |
| | | IP | CI | | Zithromax 300 mg | 3 Sachet(s) | 7.55 | 17.45 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen im Beutel: Azithromycinum 300 mg | Pfizer AG | A / SL | FB | | G | |
| | | IP | CI | | Zithromax 500 mg | 3 Sachet(s) | 11.06 | 28.45 | 10 % | | Pulver zur Herstellung einer Suspension zum Einnehmen im Beutel: Azithromycinum 500 mg | Pfizer AG | A / SL | FB | | G | |
| | | IP | CI | | Azithromycin Sandoz | 22.5 ml | PR | PR | k.A. | | Pulver zur Herstellung einer Suspension zum Einnehmen: Azithromycinum 200 mg | Sandoz
Pharmaceuticals AG | A | FB | | G | |
|
| | | IP | CI | | Dalacin C 150 mg | 16 Capsule(s) | 8.29 | 18.20 | 10 % | | Capsules: Clindamycinum 150 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Dalacin C 300 mg - T | 16 Capsule(s) | 12.93 | 30.40 | 10 % | | Capsules: Clindamycinum 300 mg | Pfizer AG | A / SL / SO | FB | | G | |
| | | IP | CI | | Dalacin C 75 mg/5 ml | 80 ml | 9.02 | 26.15 | 10 % | | Granulat zur Herstellung einer Lösung zum Einnehmen: Clindamycinum 75 mg | Pfizer AG | ● A / SL / SO | FB | | G | |
| | | IP | CI | CM | Clindamycin Pfizer 150 mg | 16 Capsule(s) | 7.54 | 17.45 | 10 % | | Capsules: Clindamycinum 150 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Clindamycin Pfizer 300 mg | 16 Capsule(s) | 11.76 | 29.20 | 10 % | | Capsules: Clindamycinum 300 mg | Pfizer AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clindamycin Sandoz 150 | 16 Capsule(s) | 7.71 | 17.60 | 10 % | | Capsules: Clindamycinum 150 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clindamycin Sandoz 300 | 16 Capsule(s) | 11.76 | 29.20 | 10 % | | Capsules: Clindamycinum 300 mg | Sandoz
Pharmaceuticals AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clindamycin Zentiva 150 mg | 16 Capsule(s) | 7.65 | 17.55 | 10 % | | Capsules: Clindamycinum 150 mg | Helvepharm AG | A / SL / SG | FB | | G | |
| | | IP | CI | | Clindamycin Zentiva 300 mg | 16 Capsule(s) | 11.76 | 29.20 | 10 % | | Capsules: Clindamycinum 300 mg | Helvepharm AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Clindamycin-Mepha 150 | 16 Capsule(s) | 7.71 | 17.60 | 10 % | | Capsules: Clindamycinum 150 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Clindamycin-Mepha 300 | 16 Capsule(s) | 11.76 | 29.20 | 10 % | | Capsules: Clindamycinum 300 mg | Mepha Pharma AG | A / SL / SG | FB | | G | |
| | | IP | CI | CM | Clindamycin Pfizer | 80 ml | 8.12 | 25.25 | 10 % | | Granulat zur Herstellung einer Lösung zum Einnehmen: Clindamycinum 75 mg | Pfizer AG | ● A / SL / SG | FB | | G | |
| | | IP | | CM | Clindamycin [Phosphat]-
Mepha i.v./i.m. 600 mg/4 ml | 5 1 ampoule(s) à 4 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 600mg / 4ml | Mepha Pharma AG | A | FB | | G | |
| | | IP | | CM | Clindamycin [Phosphat]-
Mepha i.v./i.m. 600 mg/4 ml | 25 1 ampoule(s) à 4 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 600mg / 4ml | Mepha Pharma AG | A | FB | | G | |
| | | IP | CI | CM | Clindamycin Phosphat
Pfizer i.v./i.m. 300 mg | 2 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 300 mg | Pfizer AG | A | FB | | G | |
| | | IP | CI | CM | Clindamycin Phosphat
Pfizer i.v./i.m. 300 mg | 10 x 2 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 300 mg | Pfizer AG | A | FB | | G | |
| | | IP | CI | CM | Clindamycin Phosphat
Pfizer i.v./i.m. 600 mg | 4 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 600 mg | Pfizer AG | ● A | FB | | G | |
| | | IP | CI | CM | Clindamycin Phosphat
Pfizer i.v./i.m. 600 mg | 10 x 4 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 600 mg | Pfizer AG | A | FB | | G | |
| | | IP | | | Dalacin C Phosphat 300 mg | 2 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 300 mg | Pfizer AG | A | FB | | G | |
| | | IP | | | Dalacin C Phosphat 300 mg | 10 x 2 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 300 mg | Pfizer AG | A | FB | | G | |
| | | IP | | | Dalacin C Phosphat 600 mg | 4 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 600 mg | Pfizer AG | A | FB | | G | |
| | | IP | | | Dalacin C Phosphat 600 mg | 10 x 4 ml | PR | PR | k.A. | | Injection solution: Clindamycinum 600 mg | Pfizer AG | A | FB | | G | |
| | | IP | | | Clindamycin [phosphat]
Sandoz i.v./i.m. 600
mg/4ml | 5 1 ampoule(s) à 4 ml | PR | PR | k.A. | | Konzentrat zur Herstellung einer Infusionslösung i.v. / Injektionslösung i.m: Clindamycinum 600mg / 4ml | Sandoz
Pharmaceuticals AG | A | FB | | G | |
| | | IP | | | Clindamycin [phosphat]
Sandoz i.v./i.m. 600
mg/4ml | 25 1 ampoule(s) à 4 ml | PR | PR | k.A. | | Konzentrat zur Herstellung einer Infusionslösung i.v. / Injektionslösung i.m: Clindamycinum 600mg / 4ml | Sandoz
Pharmaceuticals AG | A | FB | | G | |
